The primary objective was to characterize serum etonogestrel (ENG) concentrations
at two time points: after 3 years and after 4 years of implant use. The secondary
objective was to evaluate the effect of body mass index (BMI) on serum concentrations.
To read this article in full you will need to make a payment
Purchase one-time access:
Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online accessOne-time access price info
- For academic or personal research use, select 'Academic and Personal'
- For corporate R&D use, select 'Corporate R&D Professionals'
Subscribe:
Subscribe to ContraceptionAlready a print subscriber? Claim online access
Already an online subscriber? Sign in
Register: Create an account
Institutional Access: Sign in to ScienceDirect
Article info
Publication history
Accepted:
May 31,
2013
Received:
May 30,
2013
Identification
Copyright
© 2013 Published by Elsevier Inc.
